Ladas SD - Search Results

1

The Bcl-2/Bax system and apoptosis in ulcerative colitis.

Karamanolis DG, Kyrlagkitsis I, Konstantinou K, Papatheodoridis GV, Karameris A, Mallas E, Ladas SD, Raptis S. Karamanolis DG, et al. Among authors: ladas sd. Hepatogastroenterology. 2007 Jun;54(76):1085-8. Hepatogastroenterology. 2007. PMID: 17629044

2

Conservative treatment of acute pancreatitis: the use of somatostatin.

Ladas SD, Raptis SA. Ladas SD, et al. Hepatogastroenterology. 1992 Oct;39(5):466-9. Hepatogastroenterology. 1992. PMID: 1360937 Review.

3

Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.

Triantafyllou K, Kitsanta P, Karamanolis DG, Kittas C, Ladas SD. Triantafyllou K, et al. Among authors: ladas sd. Dig Liver Dis. 2008 Jan;40(1):39-45. doi: 10.1016/j.dld.2007.09.010. Epub 2007 Dec 11. Dig Liver Dis. 2008. PMID: 18063429

4

Therapy of acute pancreatitis with somatostatin.

Raptis SA, Ladas SD. Raptis SA, et al. Among authors: ladas sd. Scand J Gastroenterol Suppl. 1994;207:34-8. doi: 10.3109/00365529409104192. Scand J Gastroenterol Suppl. 1994. PMID: 7701265 Review.

5

Pancreatic duct width: its significance as a diagnostic criterion for pancreatic disease.

Ladas SD, Tassios PS, Giorgiotis K, Rokkas T, Theodosiou P, Raptis SA. Ladas SD, et al. Hepatogastroenterology. 1993 Feb;40(1):52-5. Hepatogastroenterology. 1993. PMID: 8462930

6

A three-day octreotide-containing helicobacter pylori eradication therapy for cure of peptic ulcers.

Ladas SD, Malamou-Lada H, Economou G, Tassios PS, Raptis SA. Ladas SD, et al. Hepatogastroenterology. 1998 May-Jun;45(21):761-4. Hepatogastroenterology. 1998. PMID: 9684129 Clinical Trial.

7

Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.

Ladas SD, Tassios PS, Raptis SA. Ladas SD, et al. Am J Gastroenterol. 2000 Feb;95(2):374-80. doi: 10.1111/j.1572-0241.2000.t01-1-01756.x. Am J Gastroenterol. 2000. PMID: 10685738

8

Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels.

Rokkas T, Liatsos C, Petridou E, Papatheodorou G, Karameris A, Ladas SD, Raptis SA. Rokkas T, et al. Among authors: ladas sd. Eur J Clin Invest. 1999 Jan;29(1):56-62. doi: 10.1046/j.1365-2362.1999.00432.x. Eur J Clin Invest. 1999. PMID: 10092990

9

The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori.

Rokkas T, Ladas SD, Triantafyllou K, Liatsos C, Petridou E, Papatheodorou G, Karameris A, Raptis SA. Rokkas T, et al. Among authors: ladas sd. Am J Med. 2001 Jun 15;110(9):703-7. doi: 10.1016/s0002-9343(01)00723-9. Am J Med. 2001. PMID: 11403754

10

Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Rokkas T, Ladas SD, Liatsos C, Panagou E, Karameris A, Raptis SA. Rokkas T, et al. Among authors: ladas sd. Dig Dis Sci. 2001 Jul;46(7):1567-72. doi: 10.1023/a:1010616710501. Dig Dis Sci. 2001. PMID: 11478511 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters